CRYSTALLINE 3-(4-HEXYLOXI-1,2,5-THIADIAZOL-3-YL)-1,2,5,6-TETRAHYDRO-1-METHYLPYRIDINE(+)L-HYDROGENTARTARTARATE, PROCESS FOR IT`S PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

摘要

The invention provides crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (+) L-hydrogentartrate, its preparation and use as a therapeutic agent.